12:00 AM
Sep 07, 2015
 |  BC Week In Review  |  Company News  |  Deals

Hovione, Invion deal

Invion and Hovione partnered to develop a dry powder formulation of Invion’s asthma candidate INV104 (zafirlukast) delivered using Hovione’s inhaler. Invion is responsible for development and regulatory submissions, and...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >